# Primary Bone Lymphoma of the Jaw Masquerading as Infection and Delaying Treatment

**Authors:** Emily Hamburger, Anne W. Beaven

PMC · DOI: 10.3390/hematolrep18010011 · Hematology Reports · 2026-01-22

## TL;DR

Two patients with jaw lymphoma were misdiagnosed as having dental infections, leading to significant delays in cancer treatment.

## Contribution

Highlights the diagnostic challenge of primary bone lymphoma of the jaw, emphasizing the need for early suspicion in unresponsive dental cases.

## Key findings

- Two patients were misdiagnosed with osteomyelitis and treated with antibiotics for 8.5 months before lymphoma was diagnosed.
- Both patients achieved remission after initiating cytotoxic chemotherapy following correct diagnosis.
- Primary bone lymphoma of the jaw is rare and often mimics dental infections, causing diagnostic delays.

## Abstract

Background: Diffuse large B cell lymphoma is an aggressive, heterogeneous yet treatable disease. Primary bone lymphoma is a lymphoma involving a single or multiple osseous sites with or without regional nodal involvement. It is exceedingly rare, representing <1% of new non-Hodgkin lymphoma cases per year. Most cases of primary bone lymphoma are diffuse large B cell lymphoma. They infrequently involve the craniofacial bones and mandible; its rarity can lead to delays in diagnosis. Case Series Presentation: Two 64-year-old male patients initially presented to local dentists with concerns of tooth pain and numbness. Both underwent extensive dental procedures including extraction and debridement, with an initial diagnosis of osteomyelitis. They were placed on long-term antibiotics. After months without improvement, further testing was pursued, including imaging and repeat biopsies. The patients were finally diagnosed with primary bone diffuse large B cell lymphoma. From the initial treatment of osteomyelitis, a median time of 8.5 months passed before diagnosis of lymphoma. Treatment with cytotoxic chemotherapy was initiated and both patients achieved remission. Conclusions: As in the two cases presented here, the initial point of entry into the medical system may be a visit to the local dentist. When patients present with periodontal complaints, it is imperative to maintain a broad differential, including lymphoma. This is especially crucial when the patient’s clinical course does not respond to initial treatment. This results in delays of diagnosis and initiation of therapy for a treatable cancer.

## Linked entities

- **Chemicals:** antibiotics (PubChem CID 46874763)
- **Diseases:** osteomyelitis (MONDO:0005246), diffuse large B cell lymphoma (MONDO:0018905), non-Hodgkin lymphoma (MONDO:0018908)

## Full-text entities

- **Genes:** SOX10 (SRY-box transcription factor 10) [NCBI Gene 6663] {aka DOM, PCWH, SOX-10, WS2E, WS4, WS4C}, MYC (MYC proto-oncogene, bHLH transcription factor) [NCBI Gene 4609] {aka MRTL, MYCC, bHLHe39, c-Myc}, CD44 (CD44 molecule (IN blood group)) [NCBI Gene 960] {aka CDW44, CSPG8, ECM-III, ECMR-III, H-CAM, HCELL}, KRT20 (keratin 20) [NCBI Gene 54474] {aka CD20, CK-20, CK20, K20, KRT21}, MME (membrane metalloendopeptidase) [NCBI Gene 4311] {aka CALLA, CD10, CMT2T, NEP, SCA43, SFE}, CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, TNFRSF8 (TNF receptor superfamily member 8) [NCBI Gene 943] {aka CD30, D1S166E, Ki-1}, S100A1 (S100 calcium binding protein A1) [NCBI Gene 6271] {aka S100, S100-alpha, S100A}
- **Diseases:** cancer (MESH:D009369), facial swelling (MESH:D004487), abscess (MESH:D000038), chronic inflammation (MESH:D007249), injury to (MESH:D014947), melanoma (MESH:D008545), prostate cancer (MESH:D011471), bone malignancies (MESH:D001859), fractures (MESH:D050723), Pain (MESH:D010146), fever (MESH:D005334), mass (MESH:C536030), peripheral nerve sheath tumor (MESH:D018317), cervical lymphadenopathy (MESH:D002575), floor of mouth lesions (MESH:D009059), I (MESH:D006969), Infection (MESH:D007239), weight loss (MESH:D015431), bone destruction (MESH:D001847), nodal (MESH:D013611), loss of sensation (MESH:D006987), ulceration (MESH:D014456), II (MESH:C537730), DLBCL (MESH:D016403), tooth instability (MESH:D043171), necrosis (MESH:D009336), Primary Bone Lymphoma (MESH:D008223), mandibular abscess (MESH:D008338), stage IIE disease (MESH:C535754), osteomyelitis (MESH:D010019), NHL (MESH:D008228)
- **Chemicals:** brentuximab vedotin (MESH:D000079963), metronidazole (MESH:D008795), clindamycin (MESH:D002981), Vancomycin (MESH:D014640), rituximab (MESH:D000069283), R-CHOP (-), Unasyn (MESH:C035444)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12922053/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12922053/full.md

## References

8 references — full list in the complete paper: https://tomesphere.com/paper/PMC12922053/full.md

---
Source: https://tomesphere.com/paper/PMC12922053